Effects of Li+ transport and intracellular binding on Li +/Mg2+ competition in bovine chromaffin cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1691, Issue 2-3, 2004, Pages 79-90

  Fonseca, C P ^a   Montezinho, L P ^a   Nabais, C ^b   Tome A R ^a   Freitas, H ^b   Geraldes, C F G C ^a   Castro, M M C A ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Atomic absorption; Fluorescence; Intracellular Mg2+; Li+ affinity; NMR

Indexed keywords

CALCIUM CHANNEL L TYPE; FLUORESCENT DYE; FURAPTRA; LITHIUM CHLORIDE; LITHIUM ION; MAGNESIUM ION; NITRENDIPINE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BINDING AFFINITY; BINDING SITE; CATTLE; CELL SPECIFICITY; CELL SUSPENSION; CELL TYPE; CHROMAFFIN CELL; CONTROLLED STUDY; DEPOLARIZATION; DRUG BINDING; DRUG BINDING SITE; DRUG TRANSPORT; ERYTHROCYTE; FLUORESCENCE SPECTROSCOPY; IMMOBILIZED CELL; INTRACELLULAR SPACE; INTRACELLULAR TRANSPORT; LYMPHOBLASTOMA; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION; PRIORITY JOURNAL;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CATTLE; CELLS, CULTURED; CHROMAFFIN CELLS; LITHIUM; MAGNESIUM; MAGNETIC RESONANCE SPECTROSCOPY; NITRENDIPINE; SPECTROPHOTOMETRY, ATOMIC;

BOVINAE; STROPHANTHUS GRATUS;

EID: 1942508907     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2003.12.005     Document Type: Article

References (63)

1. Birch N.J. Sigel H. Metal Ions in Biological Systems. vol. 14:1982;257-313 Marcel Dekker, New York.
2. Lenox R.H., McNamara R.K., Papke R.L., Manji H.K. Neurobiology of lithium: an update. J. Clin. Psychiatry. 59:1998;37-47.
3. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. 93:1996;8455-8459.
4. Hedgepeth C.M., Conrad L.J., Zhang J., Huang H.-C., Lee V.M.Y., Klein P.S. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185:1997;82-91.
5. Jope R.S. Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry. 4:1999;117-128.
6. Williams R.S., Harwood A.J. Lithium therapy and signal transduction. TIPS. 21:2000;61-64.
7. Ryves W.J., Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 280:2001;720-725.
8. Ryves W.J., Dajani R., Pearl L., Harwood A.J. Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites. Biochem. Biophys. Res. Commun. 290:2002;967-972.
9. Allison J.H., Stewart M.A. Reduced brain inositol in lithium-treated rats. Nat. New Biol. 233:1971;267-268.
10. Hallcher L.M., Sherman W.R. The effects of lithium ion and other agents on the activity of myo-inositol-1 phosphatase from bovine brain. J. Biol. Chem. 255:1980;10896-10901.
11. Bergsma T., Hiemstra H.S., De Vries B., Kaay J.V., Haastert P.J.M. Dictyostelium discoideum contains three inositol monophosphatase activities with different substrate specificities and sensitivities to lithium. Biochem. J. 314:1996;491-495.
12. 7Li nuclear-magnetic-resonance study of lithium binding to myo-inositol monophosphatase. Eur. J. Biochem. 240:1996;288-291.
13. Canales J., Buitrago F., Faraldo A., Ávalos M., Cameselle J.C. Identification of rat liver glucose-3-phosphatase as an inositol monophosphatase inhibited by lithium. Arch. Biochem. Biophys. 343:1997;27-34.
14. 2+-dependent phosphatases. J. Mol. Biol. 320:2002;1087-1094.
15. Newman M.E., Belmaker R.H. Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat. Neuropharmacology. 26:1987;211-217.
16. Mørk A., Geisler A. The effects of lithium in vitro and ex vivo on adenylate cyclase in brain are exerted by distinct mechanisms. Neuropharmacology. 28:1989;307-311.
17. Manji H.K., Potter W.Z., Lenox R.H. Signal transduction pathways. Molecular targets for lithium's actions. Arch. Gen. Psychiatry. 52:1995;531-543.
18. Avissar S., Schreiber G., Danon A., Belmaker R.H. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature. 331:1988;440-442.
19. Avissar S., Schrieber G. Ziskind-Somerfeld research award. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders. Biol. Psychiatry. 31:1992;435-459.
20. Gow I.F., Flatman P.W., Ellis D. Lithium induced changes in intracellular free magnesium concentration in isolated rat ventricular myocytes. Mol. Cell. Biochem. 198:1999;129-133.
21. + levels in human neuroblastoma SH-SY5Y cells. Bipolar Disord. 2:2000;200-204.
22. 2+ for the phosphate groups in the human erythrocyte membrane and ATP: an NMR and fluorescence study. Biochemistry. 33:1994;4101-4110.
23. 2+ competition for biomolecules. Anal. Biochem. 272:1999;1-7.
24. 31P NMR study. Biophys. J. 76:1999;2934-2942.
25. 7Li NMR and fluorescence spectroscopy. Metal Based Drugs. 7:2000;357-364.
26. 31P NMR and optical spectroscopy study. FEBS Lett. 244:1989;223-226.
27. Rong Q., Freitas D.M., Geraldes C.F.G.C. Competition between lithium and magnesium ions for the substrates of second messenger systems: a nuclear magnetic resonance study. Lithium. 5:1994;147-156.
28. iα1. Arch. Biochem. Biophys. 388:2001;7-12.
29. 6Li nuclear magnetic resonance study. Lipids. 34:1999;1211-1221.
30. + properties in neuroblastoma SH-SY5Y cells. J. Neurochem. 71:1998;1676-1684.
31. + binding in human erythrocytes. Biochemistry. 32:1993;13490-13498.
32. Trifaró J.M. The cultured chromaffin cell: a model for the study of biology and pharmacology of paraneurones. Trends Pharmacol. Sci. 3:1982;389-392.
33. Abajo F.J., Serrano-Castro M.A., Garijo B., Sánchez-Garcia P. Catecholamine release evoked by lithium from the perfused adrenal gland of the cat. Br. J. Pharmacol. 91:1987;539-546.
34. o counter-transport mechanism? Ann. N. Y. Acad. Sci. 639:1991;665-667.
35. 2+ in single chromaffin cells. Eur. J. Pharmacol. 306:1996;219-226.
36. 2+ competition in cells. Biochem. Pharmacol. 66:2003;1915-1924.
37. Brocklehurst K.W., Pollard H.B. Siddle K., Hutton J. Peptide Hormones: A Practical Approach. 1990;233-255 IRL Press, Oxford.
38. Patterson M.K. Jr. Measurement of growth and viability of cells in culture. Methods Enzymol. 58:1979;141-152.
39. Role L.W., Perlman R.L. Purification of adrenal medullary chromaffin cells by density gradient centrifugation. J. Neurosci. Methods. 2:1980;253-265.
40. Wilson S.P. Purification of adrenal chromaffin cells on Renografin gradients. J. Neurosci. Methods. 19:1987;163-171.
41. Günther T. Functional compartmentation of intracellular magnesium. Magnesium. 5:1986;53-59.
42. Murphy E., Freudenrich C.C., Levy L.A., London R.E., Lieberman M. Monitoring cytosolic free magnesium in cultured chicken heart cells by use of the fluorescent indicator Furaptra. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2981-2984.
43. Raju B., Murphy E., Levy L.A., Hall R.D., London R.E. A fluorescent indicator for measuring cytosolic free magnesium. Am. J. Physiol. 256:1989;C540-C548.
44. + transport studies of human neuroblastoma SH-SY5Y cells. Inorg. Chim. Acta. 251:1996;201-205.
45. 31P nuclear magnetic resonance study of the metabolic pools of adenosine triphosphate in cultured bovine adrenal medullary chromaffin cells. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2239-2242.
46. Ehrlich B.E., Diamond J.M. Lithium, membranes and manic depressive illness. J. Membr. Biol. 52:1980;187-200.
47. Kao L.-S., Cheung N.S. Mechanism of calcium transport across the plasma membrane of bovine chromaffin cells. J. Neurochem. 54:1990;1972-1979.
48. Powis D.A., O'Brien K.J., Grafenstein H.R.K. Calcium export by sodium-calcium exchange in bovine chromaffin cells. Cell Calcium. 12:1991;493-504.
49. 2+ exchange activity in rat skeletal myotubes: effect of lithium ions. Cell Calcium. 31:2002;37-44.
50. Duhm J. Pathways of lithium transport across the human erythrocyte membrane. Thellier M., Wissocq J.C. Lithium Kinetics. 1992;27-53 Marius, Lancashire.
51. DeCoursey T.E., Chandy K.G., Gupta S., Cahalan M.D. Voltage-dependent ion channels in T-lymphocytes. J. Neuroimmunol. 10:1985;71-95.
52. Hille B. Ionic channels in nerve membranes. Prog. Biophys. Mol. Biol. 21:1970;1-32.
53. Friedman J.E., Lelkes P.I., Lavie E., Rosenheck K., Schneeweiss F., Schneider A.S. Membrane potential and catecholamine secretion by bovine adrenal chromaffin cells: use of tetraphenylphosphonium distribution and carbocyanine dye fluorescence. J. Neurochem. 44:1985;1391-1402.
54. Kitayama S., Ohtsuki H., Morita K., Dohi T., Tsujimoto A. Bis-oxonol experiment on plasma membrane potentials of bovine adrenal chromaffin cells: depolarising stimuli and their possible interaction. Neurosci. Lett. 116:1990;275-279.
55. Johansson S. Graded action potentials generated by differentiated human neuroblastoma cells. Acta Physiol. Scand. 151:1994;331-341.
56. Fox G.Q. A morphometric analysis of exocytosis in KCl-stimulated bovine chromaffin cells. Cell Tissue Res. 284:1996;303-316.
57. Philips J.H. Dynamic aspects of chromaffin granule structure. Neuroscience. 7:1982;1595-1609.
58. 31P NMR studies. FEBS Lett. 258:1989;55-58.
59. Njus D., Sehr P.A., Radda G.K., Ritchie G.A., Seeley P.J. Phosphorous-31 nuclear magnetic resonance studies of active proton translocation in chromaffin granules. Biochemistry. 17:1978;4337-4343.
60. + electrochemical gradient across membranes of chromaffin granules is not involved in exocytosis. J. Biol. Chem. 258:1983;7506-7513.
61. Casey R.P., Njus D., Radda G.K., Sehr P.A. Active proton uptake by chromaffin granules: observation by amine distribution and phosphorus-31 nuclear magnetic resonance techniques. Biochemistry. 16:1977;972-977.
62. 31P NMR. J. Biol. Chem. 253:1978;6172-6176.
63. 2+ in bovine chromaffin cells. Metal Based Drugs. 9:2002;69-80.